SCHEMBL18924111

SCHEMBL18924111

COc1c2nc3ccc(O[Si](C)(C)C(C)(C)C)cc3oc-2c(C)c(=O)c1OC

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 4/20 0.47
CA1 P00915 4/20 0.47
CA9 Q16790 4/20 0.47
APP P05067 3/20 0.37
KDM4E B2RXH2 2/20 0.34
ALDH1A1 P00352 2/20 0.34
CYP3A4 P08684 2/20 0.34
MAPT P10636 2/20 0.34
HPGD P15428 2/20 0.34
HSD17B10 Q99714 2/20 0.34
MEN1 O00255 1/20 0.34
THRB P10828 1/20 0.34
KMT2A Q03164 1/20 0.34
ADORA3 P0DMS8 2/20 0.34
SLC22A2 O15244 1/20 0.34
SLC22A1 O15245 1/20 0.34
PREP P48147 2/20 0.33
ABCG2 Q9UNQ0 2/20 0.33
ABCB1 P08183 1/20 0.33
GABRP O00591 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16069538 0.87 APP (0.48) CA12CA1CA9APPKDM4E
SCHEMBL16069604 0.82 APP (0.49) CA12CA1CA9APPKDM4E
SCHEMBL16069530 0.81 MAPT (0.42) KDM4EALDH1A1CYP3A4MAPTHPGD
SCHEMBL18924241 0.81 CA12 (0.50) CA12CA1CA9APPKDM4E
SCHEMBL16069649 0.80 CA12 (0.45) CA12CA1CA9APPKDM4E
SCHEMBL17523137 0.80 APP (0.48) CA12CA1CA9APPKDM4E
SCHEMBL16069652 0.79 ALDH1A1 (0.38) KDM4EALDH1A1HPGD
SCHEMBL18924109 0.78 MAOB (0.49) CA12CA1CA9APPKDM4E
SCHEMBL16075040 0.76 MAPT (0.47) KDM4EALDH1A1CYP3A4MAPTHPGD
SCHEMBL16069587 0.76 MAPT (0.46) KDM4EALDH1A1CYP3A4MAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9670170-B2 Resorufin derivatives for treatment of oxidative stress disorders BIOELECTRON TECHNOLOGY CORPORATION (US) 2017-06-06 US disclosed